Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

FDA approves Santen's levofloxacin eyedrops

Aug. 22, 2000

New compounds interacting with glutathione reductase useful for cataracts, etc.

Aug. 21, 2000

QLT and Ciba Vision seek expanded labeling for Visudyne

Aug. 18, 2000

Bausch & Lomb and Muro to copromote Optivar

Aug. 16, 2000

Retinoid supplementation improves mouse model of childhood blindness

Aug. 11, 2000

FDA approves Rescula for treatment of glaucoma

Aug. 7, 2000

Visudyne approved in E.U. for treatment of wet AMD

Aug. 1, 2000

Tetracyclines as a valuable and relatively safe therapy for corneal ulceration

July 31, 2000

Topically applied GAG synthesis inhibitors useful for corneal haze

July 27, 2000

Nucleotides in development at Inspire for various clinical indications

July 20, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...